Alyeska Investment Group, L.P. - SYROS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$935,000
+1.9%
125,000
+45.1%
0.01%
-14.3%
Q2 2020$918,000
+54.8%
86,131
-13.9%
0.01%
+16.7%
Q1 2020$593,000
-14.2%
100,0000.0%0.01%
+33.3%
Q4 2019$691,000
-33.4%
100,0000.0%0.01%
-40.0%
Q3 2019$1,038,000
-73.2%
100,000
-76.0%
0.02%
-70.0%
Q2 2019$3,866,000
+113.2%
417,472
+266.8%
0.05%
+233.3%
Q1 2017$1,813,000
+31.3%
113,826
+0.2%
0.02%
+36.4%
Q4 2016$1,381,000
-11.6%
113,543
+0.8%
0.01%
-21.4%
Q3 2016$1,562,000
+22.9%
112,637
+60.9%
0.01%
+16.7%
Q2 2016$1,271,00070,0000.01%
Other shareholders

There were no reported owners of SYROS PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of SYROS PHARMACEUTICALS INC shareholders